JOHN J. DENSMORE, M.D.
Osteopathic Medicine in Charlottesville, VA

License number
Virginia 0101055272
Category
Osteopathic Medicine
Type
Hematology & Oncology
Address
Address
WEST The Cancer Ctr Hospital Dr, Charlottesville, VA 22908
Phone
(434) 924-9637
(434) 243-6086 (Fax)
(434) 980-6140
(434) 972-4266 (Fax)

Personal information

See more information about JOHN J. DENSMORE at radaris.com
Name
Address
Phone
John Densmore
1700 Silo Ct, Virginia Bch, VA 23456
(757) 303-1073

Organization information

See more information about JOHN J. DENSMORE at bizstanding.com

Department Of Hematology - John J Densmore MD

Jefferson Park Ave, Charlottesville, VA 22908

Categories:
Hematology Physicians & Surgeons, Oncology Physicians & Surgeons, Physicians & Surgeons
Phone:
(434) 924-9637 (Phone)

Professional information

John J Densmore Photo 1

Dr. John J Densmore - MD (Doctor of Medicine)

Hospitals:
Emily Couric Clinical Cancer Center
1240 Lee St, Charlottesville 22903
University of Virginia Hospital
1215 Lee St, Charlottesville 22908
Emily Couric Clinical Cancer Center
1240 Lee St, Charlottesville 22903
University of Virginia Hospital
1215 Lee St, Charlottesville 22908
Education:
Medical Schools
University Of Virginia School Of Medicine
Graduated: 1995


John Densmore Photo 2

Inhibition Of Novel Calcium Entry Pathway In Electrically Non-Excitable Cells Acting As An Anti-Proliferative Therapy

US Patent:
6413967, Jul 2, 2002
Filed:
Mar 30, 1995
Appl. No.:
08/413229
Inventors:
Lloyd S. Gray - Charlottesville VA
Doris M. Haverstick - Charlottesville VA
John J. Densmore - Charlottesville VA
Gabor Szabo - Charlottesville VA
Assignee:
The University of Virginia Patents Foundation - Charlottesville VA
International Classification:
A61K 31502
US Classification:
5142521, 51425212
Abstract:
The present invention provides methods for screening for voltage gated (VG)-selective inhibitors, novel VG-selective inhibitors, compositions containing the same, methods for inhibiting calcium entry into electrically non-excitable cells with said VG-selective inhibitors, methods for preventing proliferation of electrically non-excitable cells with said VG-selective inhibitors as well as methods of treating autoimmune diseases, preventing graft rejections, preventing apoptosis and treating cancer with the same.